RXULTI (brexpiprazole)

RXULTI (brexpiprazole)

RXULTI

brexpiprazole

0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, 4 mg film-coated tablets

Otsuka Pharmaceutical Netherlands B.V.

Medical Use

Rexulti (brexpiprazole) is a medication frequently prescribed for individuals experiencing depression, schizophrenia, or agitation related to Alzheimer’s disease dementia. As an antipsychotic, Rexulti is specifically used to manage schizophrenia in adults, a condition characterized by symptoms like delusions, disorganized thinking and speech, suspiciousness, and hallucinations (perceiving things that aren’t present). The active ingredient in Rexulti is brexpiprazole.